Dimensional Fund Advisors’s Milestone Pharmaceuticals MIST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-39,450
Closed -$31.7K 3310
2025
Q1
$31.7K Hold
39,450
﹤0.01% 3281
2024
Q4
$92.9K Hold
39,450
﹤0.01% 3248
2024
Q3
$60K Hold
39,450
﹤0.01% 3284
2024
Q2
$52.4K Hold
39,450
﹤0.01% 3310
2024
Q1
$70.6K Sell
39,450
-34,254
-46% -$55.6K ﹤0.01% 3301
2023
Q4
$123K Sell
73,704
-13,135
-15% -$35.7K ﹤0.01% 3258
2023
Q3
$269K Sell
86,839
-93,148
-52% -$290K ﹤0.01% 3159
2023
Q2
$513K Sell
179,987
-3,257
-2% -$12.3K ﹤0.01% 3059
2023
Q1
$722K Sell
183,244
-3,481
-2% -$12.7K ﹤0.01% 2969
2022
Q4
$739 Buy
186,725
+113,451
+155% +$597K ﹤0.01% 2971
2022
Q3
$673K Sell
73,274
-2,072
-3% -$15.7K ﹤0.01% 2981
2022
Q2
$448K Buy
75,346
+13,603
+22% +$83.6K ﹤0.01% 3090
2022
Q1
$397K Buy
61,743
+9,165
+17% +$57.3K ﹤0.01% 3196
2021
Q4
$345K Buy
52,578
+7,061
+16% +$42.3K ﹤0.01% 3241
2021
Q3
$260K Sell
45,517
-1,683
-4% -$9.49K ﹤0.01% 3306
2021
Q2
$260K Buy
47,200
+8,884
+23% +$50.4K ﹤0.01% 3287
2021
Q1
$222K Buy
38,316
+15,961
+71% +$117K ﹤0.01% 3273
2020
Q4
$150K Buy
+22,355
New +$150K ﹤0.01% 3256

Other funds holding MIST

Dimensional Fund Advisors's MIST Position: Q2 2025 in Review

Dimensional Fund Advisors sold out of Milestone Pharmaceuticals (MIST) in Q2 2025, closing a stake of 39,450 shares — an estimated $31.7K sold.

Dimensional Fund Advisors first reported a position in MIST in Q4 2020 and held it in 18 quarters. The position peaked at $722K in Q1 2023. 43 funds tracked by Wall St. Rank hold MIST as of Q2 2025.

  • Dimensional Fund Advisors reported no remaining Milestone Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 39,450 Milestone Pharmaceuticals shares in Q2 2025, an estimated $31.7K.
  • Dimensional Fund Advisors first reported a position in Milestone Pharmaceuticals in Q4 2020 and held it in 18 quarters.
  • Dimensional Fund Advisors's Milestone Pharmaceuticals position peaked at $722K in Q1 2023.
  • 43 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2025.

Based on Dimensional Fund Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.